共 190 条
[1]
Stamler J(2000)Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity JAMA 284 311-318
[2]
Daviglus ML(2001)Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization Circulation 104 2746-2753
[3]
Garside DB(2012)Prevalence of lipid abnormalities in the United States: the national health and nutrition examination survey 2003-2006 J Clin Lipidol 6 325-330
[4]
Dyer AR(2010)Prevalence of dyslipidemias in the Mexican National Health and Nutrition Survey 2006 Salud Publica Mex 52 S44-S53
[5]
Greenland P(2007)Blood lipid profile and prevalence of dyslipidemia in Chinese adults Biomed Environ Sci 20 329-335
[6]
Neaton JD(2014)Cardiovascular disease risk factors in the Hispanic/Latino population: lessons from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) Prog Cardiovasc Dis 57 230-236
[7]
Yusuf S(2005)Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 1267-1278
[8]
Reddy S(2013)New therapies targeting apoB metabolism for high-risk patients with inherited dyslipidaemias: what can the clinician expect? Cardiovasc Drugs Ther 27 559-567
[9]
Ounpuu S(2013)New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes Clin Ther 35 1082-1098
[10]
Anand S(2014)New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease Expert Opin Pharmacother 15 493-503